Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 6 of 6 for “"WHO clinical stage"”.
-
Evaluation of HIV test and treat strategy in Windhoek, Namibia: Development of an operational framework
… in care and viral load suppression of patients who initiated ART due to WHO clinical stage and patients who initiated ART due to HIV Test and Treat strategy. An abstraction tool was used to retrospectively abstract data from the electronic patient monitoring system (ePMS) by following a cohort …
-
Prevalence, predictors and HIV disease progression in immunovirogical discordant HIV patients at 12 months of first line antiretroviral therapy in Zambia.
… 0.03:95% CI 0.003-0.25; P= 0.001) and baseline WHO stageIV/III disease (OR 0.01:95% CI 0.01-0.59; P=0.0001) were predictors for suboptimal CD4cell response. Patient’s age, Positive RPR, TNF levels and CRP levels were not associated with suboptimal CD4cell recovery. There was no association …
-
Evaluating South African policies for linkage to and retention in HIV care using quasi-experimental methods
… individuals with CD4 counts ≤200 cells/µL or WHO clinical stage 4 disease. In 2010, treatment was extended to patients who were pregnant or who had tuberculosis and a CD4 ≤350 cells/µL, and in 2011, eligibility was extended to all patients with CD4 ≤350 cells/µL. In 2013 patients with WHO …
-
A spatial temporal analysis of survival among TB and HIV co-infected patients in Erongo region, Namibia
… the region. Mortality worsened with increasing WHO clinical stage. In multivariate analysis, the covariate Function violated the PH assumptions with a p-value of 0.01. Global Moran’s I shows that the EAs tend clusters, 0.17 (p-value<0.001) and the presence of hot spots in Erongo Region. …
-
The feasibility and effectiveness of universal antiretroviral therapy provision in adults: The Treat-All approach in the public-sector in rural Swaziland
The World Health Organization (WHO) recommends antiretroviral therapy (ART) initiation at the time of HIV diagnosis irrespective of immunological criteria – known as Treat-All – aiming at improving individual level health outcomes and reducing HIV transmission. However, concerns were raised about …
-
Human immunodeficiency virus type 1 diversity in patients initiating treatment in Northern South Africa
Background: Clinical trials carried out to determine when to start antiretroviral therapy (ART) have been showing that early ART initiation results in better health outcomes which are primarily indicated by suppressed viral loads and increase in CD4+ cell counts to healthy human ranges. This in …